Mood-support supplements: calm, sleep, and gut health

The human gut and central nervous system maintain continuous dialogue via the vagus nerve, enteric neuroendocrine pathways, and circulating microbial metabolites like short-chain fatty acids (SCFAs). Enterochromaffin cells in the gut lumen synthesize over 90 percent of peripheral serotonin, yet this peripheral pool does not cross the blood-brain barrier. Cryan et al. 2019 review on the microbiota-gut-brain axis (PMID 31460832)

Instead, the gut microbiome influences central neurochemistry through immune cytokine regulation, vagal afferent firing, and tryptophan metabolic pathways. The term psychobiotics describes specific live microorganisms that confer mental health benefits when consumed in adequate quantities. Cryan et al. 2019 review on the microbiota-gut-brain axis (PMID 31460832) NCCIH probiotics: what you need to know

Evidence for psychobiotics is strictly strain-dependent. In a landmark double-blind randomized controlled trial, Messaoudi and colleagues demonstrated that daily administration of a specific combination of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 significantly reduced 24-hour urinary free cortisol and self-reported psychological stress scores. Messaoudi et al. 2011 clinical trial of psychobiotics on anxiety and cortisol (PMID 20974015)

Generic probiotics that list Lactobacillus acidophilus without an alphanumeric strain designation cannot claim to support mood or stress resilience, as these clinical outcomes belong exclusively to investigated strains. NCCIH probiotics: what you need to know FDA dietary supplement labeling guide

Magnesium serves as an essential cofactor in hundreds of enzymatic reactions, exerting critical control over the hypothalamic-pituitary-adrenal (HPA) axis. Inadequate magnesium intake exacerbates neuroendocrine stress responses, promoting increased release of corticotropin-releasing factor and adrenal cortisol. NIH ODS magnesium fact sheet Tarleton et al. 2017 clinical trial of magnesium on depression and anxiety (PMID 28654669)

In a randomized clinical trial published by Tarleton and colleagues, daily supplementation with 248 milligrams of elemental magnesium led to statistically significant and clinically meaningful improvements in generalized anxiety and depression scores within two weeks of initiation. Tarleton et al. 2017 clinical trial of magnesium on depression and anxiety (PMID 28654669)

To achieve these benefits without gastrointestinal disruption, consumers should prioritize bioavailable amino acid chelates such as magnesium bisglycinate or magnesium malate, avoiding poorly absorbed magnesium oxide that primarily causes osmotic loose stools. NIH ODS magnesium fact sheet FDA dietary supplement labeling guide

L-theanine is an amino acid analogue that readily crosses the blood-brain barrier to exert rapid modulatory effects on cerebral neurotransmission. Structurally related to glutamic acid, it binds competitively to post-synaptic glutamate receptors while increasing central levels of inhibitory neurotransmitters. Randomized controlled trial of L-theanine for stress-related symptoms

Clinical trials indicate that a standardized dose of 200 milligrams of L-theanine significantly decreases salivary alpha-amylase (a clinical biomarker of sympathetic nervous system activation) and reduces subjective state anxiety during acute cognitive stress tests without causing motor sedation. Randomized controlled trial of L-theanine for stress-related symptoms

Commercial wellness marketing frequently attempts to merge stress relief, deep sleep, and microbiome nourishment into a single powder or drink mix. Physical volumetric constraints make this formulation strategy inherently flawed. FDA dietary supplement labeling guide FTC health products compliance guidance

Delivering therapeutic doses of magnesium (250 mg elemental), L-theanine (200 mg), prebiotic fiber (3 to 5 grams), and live psychobiotic cultures would require a substantial multi-gram serving size. Instead, manufacturers typically group 10 different ingredients inside a 500-milligram proprietary blend, severely underdosing every component. FDA dietary supplement labeling guide FTC health products compliance guidance

Consumers taking prescription psychiatric medications, such as selective serotonin reuptake inhibitors (SSRIs) or monoamine oxidase inhibitors (MAOIs), must avoid mood supplements containing 5-HTP, L-tryptophan, or St. Johns wort due to the severe clinical risk of serotonin syndrome. NCCIH using dietary supplements wisely

Dietary supplements are not formulated or approved to diagnose, treat, or cure clinical depression, generalized anxiety disorder, or panic disorder. Persistent emotional distress requires comprehensive evaluation by a licensed mental health professional. NCCIH using dietary supplements wisely FTC health products compliance guidance

For research and educational purposes only. Not medical advice. FDA dietary supplement labeling guide

• Clinically significant dose guide
• Proprietary blend guide
• Gut microbiome guide